Stocklytics Platform
Asset logo for symbol VXRT
Vaxart
VXRT62
$0.78arrow_drop_down2.52%-$0.02
Penny Stock
Asset logo for symbol VXRT
VXRT62

$0.78

arrow_drop_down2.52%

Performance History

Chart placeholder
Key Stats
Open$0.81
Prev. Close$0.80
EPS-0.40
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$179.66M
PE Ratio-
LOWHIGH
Day Range0.76
0.84
52 Week Range0.52
1.54
Ratios
EPS-0.40

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Vaxart (VXRT)

Vaxart Inc (VXRT) is a clinical-stage biotechnology company focused on the development of oral recombinant vaccines. The company's proprietary technology enables the delivery of vaccines through convenient oral tablets rather than traditional injections. This approach offers numerous advantages, including ease of administration and improved patient compliance. Vaxart is developing vaccines for a range of infectious diseases, including influenza, COVID-19, and norovirus.
The stock price history of Vaxart Inc has experienced significant volatility in recent years. It has seen both steep declines and substantial increases, reflecting the speculative nature of the biotech sector. Investors should carefully consider the risks associated with investing in a clinical-stage company and be prepared for fluctuations in the stock price.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Cezar Andrei Floroiu M.B.A.
Headquarters
South San Francisco
Employees
164
Exchange
NASDAQ
add Vaxart  to watchlist

Keep an eye on Vaxart

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the 52-week high and low for Vaxart (VXRT)?

For Vaxart (VXRT), the 52-week high is $1.54, which is 94.99% from the current price. The 52-week low is $0.52, the current price is 51.88% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

What is Vaxart 's (VXRT) price per share?

The current price per share for Vaxart (VXRT) is $0.79. The stock has seen a price change of -$0.02 recently, indicating a -2.52% change. This reflects the stock's recent market performance and investor sentiment.
help

Is Vaxart (VXRT) a growth stock?

Vaxart (VXRT) has shown an average price growth of -1.38% over the past three years. It has received a score of 11 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Vaxart as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Vaxart (VXRT) stock price performance year to date (YTD)?

As of the latest data, Vaxart (VXRT) has a year-to-date price change of 19.29%. Over the past month, the stock has experienced a price change of 26.31%. Over the last three months, the change has been -0.2%. Over the past six months, the figure is 19.78%. Looking at a longer horizon, the five-year price change stands at 128.86%.
help

Is Vaxart (VXRT) a profitable company?

Vaxart (VXRT) has a net income of -$82.46M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -253.96% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $7.38M, although specific revenue growth data is currently not available. Operating income is noted at -$83.35M. Furthermore, the EBITDA is -$66.26M.
help

What is the market capitalization of Vaxart (VXRT)?

Vaxart (VXRT) has a market capitalization of $179.66M. The average daily trading volume is 0.79, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level